Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients
Top Cited Papers
Open Access
- 28 December 2021
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-12
Abstract
Purpose. To generate a signature based on anoikis-related genes (ARGs) for endometrial carcinoma (EC) patients and elucidate the molecular mechanisms in EC. Methods. On the basis of TCGA-UCEC dataset, we identified specific anoikis-related genes (ARGs) in EC. Cox-relative regression methods were used to generate an anoikis-related signature (ARS). The possible biological pathways of ARS-related genes were analyzed by GSEA. The clinical potency and immune status of ARS were analyzed by CIBERSORT method, ssGSEA algorithm, Tumor Immune Dysfunction and Exclusion (TIDE) analysis. Moreover, the expression patterns of ARS genes were verified by HPA database. Results. Seven anoikis genes (CDKN2A, E2F1, ENDOG, EZH2, HMGA1, PLK1, and SLC2A1) were determined to develop a prognostic ARS. Both genes of ARS were closely bound up with the prognosis of EC patients. The ARS could accurately classify EC cases with different clinical outcome and mirror the specific immune status of EC. We observed that ARS-high patients could not benefit from immunotherapy. Finally, all the hub genes of ARS were proved to be upregulated in EC tissues by immunohistology. Conclusion. ARS can be used to stratify the risk and forecast the survival outcome of EC patients and provide prominent reference for individualized treatment in EC.Keywords
This publication has 32 references indexed in Scilit:
- E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axisCell Death & Disease, 2017
- LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signalingBiomedicine & Pharmacotherapy, 2016
- HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancerBiomedicine & Pharmacotherapy, 2016
- Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway2016
- Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutationsCancer Biology & Therapy, 2015
- Improving survival after endometrial cancer: the big pictureJournal of Gynecologic Oncology, 2015
- Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestrationCell Death & Differentiation, 2014
- CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradationCell Death & Differentiation, 2012
- Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients with Endometrial CancerInternational Journal of Gynecological Cancer, 2011
- Anoikis resistance and tumor metastasisCancer Letters, 2008